Compare FOLD & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOLD | MMSI |
|---|---|---|
| Founded | 2002 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 4.9B |
| IPO Year | 2006 | 1996 |
| Metric | FOLD | MMSI |
|---|---|---|
| Price | $14.36 | $76.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 9 |
| Target Price | $27.25 | ★ $103.56 |
| AVG Volume (30 Days) | ★ 4.2M | 593.5K |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 50.00 | 4.93 |
| EPS | N/A | ★ 2.13 |
| Revenue | N/A | ★ $1,515,906,000.00 |
| Revenue This Year | $20.55 | $7.99 |
| Revenue Next Year | $18.34 | $5.62 |
| P/E Ratio | ★ N/A | $36.04 |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $5.66 | $74.58 |
| 52 Week High | $14.38 | $107.27 |
| Indicator | FOLD | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 73.35 | 35.53 |
| Support Level | $14.21 | N/A |
| Resistance Level | $14.37 | $85.09 |
| Average True Range (ATR) | 0.04 | 2.56 |
| MACD | -0.04 | -0.35 |
| Stochastic Oscillator | 93.75 | 21.88 |
Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.